Abstract
ST 1059, the pharmacologically active metabolite of midodrine, is a powerful vasoconstrictor compound, acting by stimulation of alpha-receptors. It elicited 80% of noradrenaline-induced contraction of human veins.
MeSH terms
-
Dihydroergotamine / pharmacology*
-
Ethanolamines / pharmacology*
-
Etilefrine / pharmacology*
-
Humans
-
In Vitro Techniques
-
Midodrine / analogs & derivatives
-
Midodrine / pharmacology*
-
Muscle, Smooth, Vascular / drug effects
-
Norepinephrine / pharmacology*
-
Phenylephrine / analogs & derivatives*
-
Vasoconstrictor Agents*
-
Veins / drug effects
Substances
-
Ethanolamines
-
Vasoconstrictor Agents
-
Phenylephrine
-
ST 1059
-
Dihydroergotamine
-
Midodrine
-
Norepinephrine
-
Etilefrine